Annexin A1 Mitigates Blood–Brain Barrier Disruption in a Sepsis‐Associated Encephalopathy Model by Enhancing the Expression of Occludin and Zonula Occludens‐1 ( ZO ‐1)
CNS Neuroscience & Therapeutics · 2024-12 · 30 (12)
DOI: 10.1111/cns.70173 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 27.12.2024. Verfasst von Yao Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Che…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Sepsis-Associated Encephalopathy, Annexin A1, Zonula Occludens-1 Protein. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial People's Hospital.
Themen: Sepsis
Abstract (Originalsprache)
Aims
This study investigated the protective role of Annexin A1 (ANXA1) in sepsis‐associated encephalopathy (SAE) by examining its effects on brain vascular endothelium and blood–brain barrier (BBB) integrity.
Methods
Mice were divided into four groups: wild type (WT), cecal ligation and puncture (CLP), ANXA1 knockout (ANXA1[−/−]), and ANXA1(−/−) with CLP. Neurobehavioral changes were assessed using the Y‐maze test, while BBB integrity was evaluated through Evans blue dye (EBD) staining and permeability tests with fluorescein isothiocyanate (FITC)‐dextran.
Results
Results showed that ANXA1 levels were reduced in septic mice, and its deficiency exacerbated cognitive impairment and survival rate reduction. ANXA1 deficiency also upregulated proinflammatory cytokines and adhesion molecules, worsened BBB impairment, and altered expression of tight junction proteins and VEGF‐A/VEGF‐R2. In vitro, ANXA1 Ac2‐26 prevented LPS‐induced increased permeability in bEnd.3 cells by restoring tight junction proteins and reducing VEGF‐A/VEGF‐R2 expression. Notably, VEGF‐A negated the protective effects of ANXA1 Ac2‐26.
Conclusion
The study concludes that ANXA1 reduces BBB permeability to protect against sepsis‐induced brain dysfunction via VEGF‐A/VEGF‐R2 regulation of tight junction proteins, suggesting ANXA1 as a potential therapeutic for SAE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
ORCID-Profile: Xinran Gong
Förderung
- Sichuan Provincial People's Hospital
Zitieren
APA
Li, Y., Zhou, F., You, J., & Gong, X. (2024). Annexin A1 Mitigates Blood–Brain Barrier Disruption in a Sepsis‐Associated Encephalopathy Model by Enhancing the Expression of Occludin and Zonula Occludens‐1 ( ZO ‐1). CNS Neuroscience & Therapeutics, 30(12). https://doi.org/10.1111/cns.70173
Vancouver
Li Y, Zhou F, You J, Gong X. Annexin A1 Mitigates Blood–Brain Barrier Disruption in a Sepsis‐Associated Encephalopathy Model by Enhancing the Expression of Occludin and Zonula Occludens‐1 ( ZO ‐1). CNS Neuroscience & Therapeutics. 2024;30(12). doi:10.1111/cns.70173
BibTeX
@article{Li2024,
author = {Li, Yao and Zhou, Fang and You, Jiyue and Gong, Xinran},
title = {Annexin A1 Mitigates Blood–Brain Barrier Disruption in a Sepsis‐Associated Encephalopathy Model by Enhancing the Expression of Occludin and Zonula Occludens‐1 ( ZO ‐1)},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {12},
doi = {10.1111/cns.70173}
}
EUVIMED